Nifty
Sensex
:
:
13258.55
45079.55
124.65 (0.95%)
446.90 (1.00%)

Pharmaceuticals & Drugs - Domestic

Rating :
67/99

BSE: 506943 | NSE: JBCHEPHARM

994.25
04-Dec-2020
  • Open
  • High
  • Low
  • Previous Close
  •  981.05
  •  1002.30
  •  981.05
  •  992.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  72685
  •  721.25
  •  1149.90
  •  398.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 7,680.29
  • 24.80
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 7,681.38
  • 1.11%
  • 4.72

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.91%
  • 1.83%
  • 20.73%
  • FII
  • DII
  • Others
  • 7.25%
  • 11.64%
  • 2.64%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.14
  • 7.58
  • 7.87

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.98
  • 12.88
  • 13.65

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.92
  • 11.04
  • 25.28

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.44
  • 17.21
  • 17.27

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.99
  • 2.39
  • 2.43

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.57
  • 10.56
  • 10.45

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
443.56
456.42
-2.82%
522.29
446.11
17.08%
443.57
418.91
5.89%
428.63
382.03
12.20%
Expenses
333.47
356.16
-6.37%
366.86
350.13
4.78%
351.83
353.38
-0.44%
339.04
304.05
11.51%
EBITDA
110.10
100.26
9.81%
155.42
95.98
61.93%
91.74
65.54
39.98%
89.59
77.98
14.89%
EBIDTM
24.82%
21.97%
29.76%
21.51%
14.01%
15.65%
20.90%
20.41%
Other Income
8.39
18.51
-54.67%
22.69
12.61
79.94%
3.17
15.65
-79.74%
16.38
15.82
3.54%
Interest
1.72
0.87
97.70%
3.75
0.80
368.75%
0.50
1.31
-61.83%
0.85
1.30
-34.62%
Depreciation
17.45
16.39
6.47%
17.29
15.80
9.43%
17.39
11.60
49.91%
16.75
14.66
14.26%
PBT
99.33
101.51
-2.15%
157.07
91.99
70.75%
67.02
68.28
-1.85%
88.37
77.84
13.53%
Tax
25.41
7.75
227.87%
37.57
29.87
25.78%
16.95
21.49
-21.13%
21.93
27.89
-21.37%
PAT
73.92
93.76
-21.16%
119.51
62.11
92.42%
50.07
46.79
7.01%
66.45
49.95
33.03%
PATM
16.67%
20.54%
22.88%
13.92%
7.11%
11.17%
15.50%
13.08%
EPS
9.56
12.13
-21.19%
15.46
8.04
92.29%
6.48
6.05
7.11%
8.60
6.46
33.13%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
1,838.05
1,774.73
1,643.20
1,413.77
1,368.32
1,231.58
1,144.21
1,021.86
866.13
801.87
890.79
Net Sales Growth
7.90%
8.00%
16.23%
3.32%
11.10%
7.64%
11.97%
17.98%
8.01%
-9.98%
 
Cost Of Goods Sold
5,114.53
630.80
596.46
542.41
552.00
491.41
341.40
413.95
371.52
320.07
277.04
Gross Profit
-3,276.48
1,143.93
1,046.74
871.35
816.32
740.17
802.81
607.92
494.60
481.80
613.75
GP Margin
-178.26%
64.46%
63.70%
61.63%
59.66%
60.10%
70.16%
59.49%
57.10%
60.08%
68.90%
Total Expenditure
1,391.20
1,397.15
1,337.36
1,214.64
1,135.93
1,025.55
964.09
873.67
760.48
701.55
698.43
Power & Fuel Cost
-
61.54
63.29
58.28
54.89
55.28
53.02
46.61
39.75
29.89
23.34
% Of Sales
-
3.47%
3.85%
4.12%
4.01%
4.49%
4.63%
4.56%
4.59%
3.73%
2.62%
Employee Cost
-
322.92
288.18
251.10
217.34
175.31
159.56
143.67
130.05
112.66
124.93
% Of Sales
-
18.20%
17.54%
17.76%
15.88%
14.23%
13.94%
14.06%
15.02%
14.05%
14.02%
Manufacturing Exp.
-
140.70
150.49
139.83
131.45
119.35
223.53
102.44
61.75
52.97
60.85
% Of Sales
-
7.93%
9.16%
9.89%
9.61%
9.69%
19.54%
10.02%
7.13%
6.61%
6.83%
General & Admin Exp.
-
48.89
52.97
53.96
42.26
34.82
32.46
31.69
27.94
31.31
38.21
% Of Sales
-
2.75%
3.22%
3.82%
3.09%
2.83%
2.84%
3.10%
3.23%
3.90%
4.29%
Selling & Distn. Exp.
-
116.95
113.59
87.44
78.27
72.72
75.13
73.59
56.04
68.65
131.60
% Of Sales
-
6.59%
6.91%
6.18%
5.72%
5.90%
6.57%
7.20%
6.47%
8.56%
14.77%
Miscellaneous Exp.
-
75.36
72.38
81.61
59.72
76.65
79.01
61.72
73.44
86.00
131.60
% Of Sales
-
4.25%
4.40%
5.77%
4.36%
6.22%
6.91%
6.04%
8.48%
10.72%
4.77%
EBITDA
446.85
377.58
305.84
199.13
232.39
206.03
180.12
148.19
105.65
100.32
192.36
EBITDA Margin
24.31%
21.28%
18.61%
14.09%
16.98%
16.73%
15.74%
14.50%
12.20%
12.51%
21.59%
Other Income
50.63
50.90
41.44
55.29
50.16
56.65
10.89
37.70
27.87
28.98
6.16
Interest
6.82
3.26
4.65
3.49
5.37
10.65
6.82
5.93
5.28
24.03
10.49
Depreciation
68.88
66.32
55.64
56.97
47.22
41.22
38.64
28.02
24.66
22.42
22.79
PBT
411.79
358.89
286.99
193.95
229.94
210.82
145.55
151.94
103.57
82.85
165.24
Tax
101.86
76.50
93.02
55.23
45.55
49.58
45.14
25.95
24.13
165.53
25.92
Tax Rate
24.74%
21.93%
32.41%
28.48%
19.81%
23.52%
31.01%
29.68%
23.30%
19.63%
15.69%
PAT
309.95
272.04
193.47
138.34
184.06
161.14
100.41
61.50
79.44
677.91
139.32
PAT before Minority Interest
309.60
272.39
193.97
138.72
184.40
161.24
100.41
61.50
79.44
677.91
139.32
Minority Interest
-0.35
-0.35
-0.50
-0.38
-0.34
-0.10
0.00
0.00
0.00
0.00
0.00
PAT Margin
16.86%
15.33%
11.77%
9.79%
13.45%
13.08%
8.78%
6.02%
9.17%
84.54%
15.64%
PAT Growth
22.70%
40.61%
39.85%
-24.84%
14.22%
60.48%
63.27%
-22.58%
-88.28%
386.58%
 
EPS
40.10
35.19
25.03
17.90
23.81
20.85
12.99
7.96
10.28
87.70
18.02

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
1,435.49
1,480.12
1,441.56
1,363.67
1,183.84
994.87
1,042.81
1,020.27
969.95
691.54
Share Capital
15.46
16.05
16.71
16.96
16.96
16.96
16.95
16.94
16.94
16.90
Total Reserves
1,420.03
1,464.08
1,424.84
1,346.70
1,166.87
977.91
1,025.82
1,003.22
952.83
674.31
Non-Current Liabilities
62.72
64.84
45.66
26.98
31.02
32.62
31.93
40.45
39.52
36.50
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.09
0.22
0.40
0.54
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.40
0.40
7.03
12.14
11.99
Long Term Provisions
7.39
5.73
9.67
12.56
10.43
12.03
12.19
8.23
8.27
7.71
Current Liabilities
515.77
781.54
736.50
693.46
797.22
459.75
276.27
239.48
188.32
271.33
Trade Payables
123.79
117.37
110.39
98.98
90.85
77.51
60.75
60.51
37.09
50.21
Other Current Liabilities
143.88
93.10
119.75
122.15
138.73
103.74
98.06
101.15
78.75
61.22
Short Term Borrowings
32.04
25.80
29.29
48.86
193.02
126.88
81.71
37.28
55.23
133.36
Short Term Provisions
216.06
545.27
477.06
423.47
374.61
151.62
35.76
40.54
17.26
26.54
Total Liabilities
2,016.48
2,329.30
2,226.49
2,086.29
2,013.75
1,487.24
1,351.01
1,300.20
1,197.79
999.37
Net Block
651.26
620.93
639.50
679.44
440.22
328.56
310.55
334.41
276.31
258.39
Gross Block
1,177.43
1,084.83
1,053.76
1,038.55
753.75
601.67
540.54
537.46
456.51
420.25
Accumulated Depreciation
526.17
463.89
414.25
359.10
313.53
273.11
229.99
203.06
180.19
161.85
Non Current Assets
740.83
740.80
717.89
879.15
831.58
586.31
370.37
356.49
331.58
278.78
Capital Work in Progress
16.17
15.09
17.40
3.76
134.89
55.17
46.36
4.81
39.00
3.75
Non Current Investment
69.45
95.88
49.96
185.84
231.42
184.83
2.75
2.99
3.00
3.94
Long Term Loans & Adv.
3.59
8.31
10.15
9.43
22.63
17.74
10.71
14.28
13.27
12.70
Other Non Current Assets
0.36
0.59
0.88
0.67
2.43
0.00
0.00
0.00
0.00
0.00
Current Assets
1,275.65
1,588.51
1,508.59
1,207.14
1,182.16
900.94
980.65
943.71
866.22
720.60
Current Investments
333.81
360.65
383.77
224.96
247.28
366.78
497.26
394.68
298.92
81.05
Inventories
274.67
243.76
213.73
200.17
187.98
150.27
134.40
104.53
101.03
111.67
Sundry Debtors
345.43
308.22
300.73
265.97
272.64
262.35
235.51
191.27
136.05
345.58
Cash & Bank
30.95
36.80
29.92
13.39
12.90
25.19
11.81
156.23
219.53
126.89
Other Current Assets
290.80
33.23
12.94
14.36
461.34
96.35
101.68
96.99
110.69
55.41
Short Term Loans & Adv.
272.33
605.85
567.50
488.30
458.83
95.97
101.48
96.84
110.29
54.66
Net Current Assets
759.88
806.97
772.10
513.68
384.94
441.19
704.37
704.23
677.90
449.27
Total Assets
2,016.48
2,329.31
2,226.48
2,086.29
2,013.74
1,487.25
1,351.02
1,300.20
1,197.80
999.38

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
275.37
194.33
122.92
201.13
140.41
126.66
-13.98
84.20
879.69
133.92
PBT
348.89
286.99
193.95
229.94
212.23
145.55
87.44
103.57
843.44
165.34
Adjustment
7.95
23.72
16.91
13.11
-1.40
38.51
20.75
-4.40
33.13
16.60
Changes in Working Capital
9.32
-51.47
-47.07
5.92
-16.96
-19.52
-93.71
9.47
167.35
-15.87
Cash after chg. in Working capital
366.17
259.24
163.79
248.97
193.88
164.53
14.49
108.65
1,043.91
166.07
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-90.80
-64.91
-40.87
-47.84
-53.47
-37.87
-28.47
-24.45
-164.22
-32.15
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
24.30
-27.67
-20.68
-45.31
-27.62
-111.89
-142.50
-116.05
-260.92
-89.46
Net Fixed Assets
-94.42
-29.82
-29.56
-152.86
-187.76
-69.64
-55.43
-41.77
-69.55
-32.72
Net Investments
53.26
-22.80
-22.92
67.89
-14.16
-61.38
-102.46
-95.95
-214.42
-60.83
Others
65.46
24.95
31.80
39.66
174.30
19.13
15.39
21.67
23.05
4.09
Cash from Financing Activity
-306.05
-155.74
-59.52
-183.84
-99.62
-1.39
12.04
-31.45
-526.12
4.56
Net Cash Inflow / Outflow
-6.38
10.92
42.72
-28.02
13.17
13.38
-144.43
-63.30
92.65
49.02
Opening Cash & Equivalents
32.14
21.24
-21.47
6.54
-5.46
11.81
156.23
219.53
126.89
77.86
Closing Cash & Equivalent
25.75
32.14
21.24
-21.47
9.42
25.19
11.81
156.23
219.53
126.89

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
185.75
184.47
172.50
160.77
139.57
117.31
123.07
119.21
113.34
80.86
ROA
12.54%
8.52%
6.43%
8.99%
9.21%
7.08%
4.64%
6.36%
61.71%
15.17%
ROE
18.69%
13.28%
9.89%
14.48%
14.80%
9.86%
5.99%
8.07%
82.49%
22.35%
ROCE
23.69%
19.59%
13.70%
16.87%
17.72%
13.49%
8.50%
10.41%
92.09%
22.63%
Fixed Asset Turnover
1.57
1.54
1.35
1.53
1.82
2.03
1.92
1.76
1.85
2.22
Receivable days
67.22
67.63
73.15
71.84
79.28
78.41
75.30
68.16
108.62
140.48
Inventory Days
53.31
50.81
53.43
51.77
50.12
44.83
42.16
42.80
47.97
39.77
Payable days
32.74
32.21
33.66
32.86
32.45
27.82
26.91
26.15
26.89
25.89
Cash Conversion Cycle
87.79
86.23
92.93
90.75
96.95
95.43
90.54
84.81
129.69
154.35
Total Debt/Equity
0.02
0.02
0.02
0.04
0.16
0.13
0.09
0.05
0.07
0.25
Interest Cover
108.09
62.74
56.54
43.81
20.80
22.33
15.74
20.61
36.10
16.75

News Update:


  • CCI approves proposal of Tau Investment to acquire shares in JB Chemicals
    27th Aug 2020, 12:35 PM

    The proposed combination envisages acquisition of up to 64.90% of the share capital of JB Chemicals & Pharmaceuticals by Tau Investment

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.